Clinical trial NCT02691910 - References

Malaria, Vivax — Efficacy of Chloroquine (CQ) Alone Compared to Concomitant CQ and Primaquine for Plasmodium Vivax Infection

Citation(s)

•   Alvarez G, Piñeros JG, Tobón A, Ríos A, Maestre A, Blair S, Carmona-Fonseca J
  Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia. Am J Trop Med Hyg. 2006 Oct;75(4):605-9. Erratum in: Am J Trop Med Hyg. 2006 Dec;75(6):1238.
•   Añez A, Navarro-Costa D, Yucra O, Garnica C, Melgar V, Moscoso M, Arteaga R, Nakao G
  [Therapeutic response of Plasmodium vivax to chloroquine in Bolivia]. Biomedica. 2012 Oct-Dec;32(4):527-35. doi: 10.1590/S0120-41572012000400008. Spanish.
•   Arias AE, Corredor A
  Low response of Colombian strains of Plasmodium vivax to classical antimalarial therapy. Trop Med Parasitol. 1989 Mar;40(1):21-3.
•   Baird JK, Leksana B, Masbar S, Fryauff DJ, Sutanihardja MA, Suradi, Wignall FS, Hoffman SL
  Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. Am J Trop Med Hyg. 1997 Jun;56(6):621-6. Review.
•   Baird JK, Tiwari T, Martin GJ, Tamminga CL, Prout TM, Tjaden J, Bravet PP, Rawlins S, Ferrel M, Carucci D, Hoffman SL
  Chloroquine for the treatment of uncomplicated malaria in Guyana. Ann Trop Med Parasitol. 2002 Jun;96(4):339-48.
•   Baird JK
  Resistance to therapies for infection by Plasmodium vivax. Clin Microbiol Rev. 2009 Jul;22(3):508-34. doi: 10.1128/CMR.00008-09. Review.
•   Baird KJ, Maguire JD, Price RN
  Diagnosis and treatment of Plasmodium vivax malaria. Adv Parasitol. 2012;80:203-70. doi: 10.1016/B978-0-12-397900-1.00004-9. Review.
•   Bray PG, Deed S, Fox E, Kalkanidis M, Mungthin M, Deady LW, Tilley L
  Primaquine synergises the activity of chloroquine against chloroquine-resistant P. falciparum. Biochem Pharmacol. 2005 Oct 15;70(8):1158-66.
•   Carmona-Fonseca J, Maestre A
  Prevention of Plasmodium vivax malaria recurrence: efficacy of the standard total dose of primaquine administered over 3 days. Acta Trop. 2009 Nov;112(2):188-92. doi: 10.1016/j.actatropica.2009.07.024. Epub 2009 Aug 3.
•   Castillo CM, Osorio LE, Palma GI
  Assessment of therapeutic response of Plasmodium vivax and Plasmodium falciparum to chloroquine in a Malaria transmission free area in Colombia. Mem Inst Oswaldo Cruz. 2002 Jun;97(4):559-62.
•   de Santana Filho FS, Arcanjo AR, Chehuan YM, Costa MR, Martinez-Espinosa FE, Vieira JL, Barbosa Md, Alecrim WD, Alecrim Md
  Chloroquine-resistant Plasmodium vivax, Brazilian Amazon. Emerg Infect Dis. 2007 Jul;13(7):1125-6. doi: 10.3201/eid1307.061386.
•   Egan TJ
  Chloroquine and primaquine: combining old drugs as a new weapon against falciparum malaria? Trends Parasitol. 2006 Jun;22(6):235-7. Epub 2006 Apr 3.
•   Garavelli PL, Corti E
  Chloroquine resistance in Plasmodium vivax: the first case in Brazil. Trans R Soc Trop Med Hyg. 1992 Mar-Apr;86(2):128.
•   Marques MM, Costa MR, Santana Filho FS, Vieira JL, Nascimento MT, Brasil LW, Nogueira F, Silveira H, Reyes-Lecca RC, Monteiro WM, Lacerda MV, Alecrim MG
  Plasmodium vivax chloroquine resistance and anemia in the western Brazilian Amazon. Antimicrob Agents Chemother. 2014;58(1):342-7. doi: 10.1128/AAC.02279-12. Epub 2013 Oct 28.
•   Naing C, Aung K, Win DK, Wah MJ
  Efficacy and safety of chloroquine for treatment in patients with uncomplicated Plasmodium vivax infections in endemic countries. Trans R Soc Trop Med Hyg. 2010 Nov;104(11):695-705. doi: 10.1016/j.trstmh.2010.08.009. Epub 2010 Sep 20. Review.
•   Osorio L, Pérez Ldel P, González IJ
  [Assessment of the efficacy of antimalarial drugs in Tarapacá, in the Colombian Amazon basin]. Biomedica. 2007 Mar;27(1):133-40. Epub 2007 May 31. Spanish.
•   Phillips EJ, Keystone JS, Kain KC
  Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America. Clin Infect Dis. 1996 Nov;23(5):1171-3.
•   Rieckmann KH, Davis DR, Hutton DC
  Plasmodium vivax resistance to chloroquine? Lancet. 1989 Nov 18;2(8673):1183-4.
•   Ruebush TK 2nd, Zegarra J, Cairo J, Andersen EM, Green M, Pillai DR, Marquiño W, Huilca M, Arévalo E, Garcia C, Solary L, Kain KC
  Chloroquine-resistant Plasmodium vivax malaria in Peru. Am J Trop Med Hyg. 2003 Nov;69(5):548-52.
•   Russell B, Chalfein F, Prasetyorini B, Kenangalem E, Piera K, Suwanarusk R, Brockman A, Prayoga P, Sugiarto P, Cheng Q, Tjitra E, Anstey NM, Price RN
  Determinants of in vitro drug susceptibility testing of Plasmodium vivax. Antimicrob Agents Chemother. 2008 Mar;52(3):1040-5. doi: 10.1128/AAC.01334-07. Epub 2008 Jan 7.
•   Russell BM, Udomsangpetch R, Rieckmann KH, Kotecka BM, Coleman RE, Sattabongkot J
  Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic. Antimicrob Agents Chemother. 2003 Jan;47(1):170-3.
•   Soto J, Toledo J, Gutierrez P, Luzz M, Llinas N, Cedeño N, Dunne M, Berman J
  Plasmodium vivax clinically resistant to chloroquine in Colombia. Am J Trop Med Hyg. 2001 Aug;65(2):90-3.
•   Villalobos-Salcedo JM, Tada MS, Kimura E, Menezes MJ, Pereira da Silva LH
  In-vivo sensitivity of Plasmodium vivax isolates from Rond nia (western Amazon region, Brazil) to regimens including chloroquine and primaquine. Ann Trop Med Parasitol. 2000 Dec;94(8):749-58.

Efficacy of Chloroquine (CQ) Alone Compared to Concomitant CQ and Primaquine (PQ) for the Treatment of Uncomplicated Plasmodium Vivax Infection

Details for clinical trial NCT02691910